
Alnylam Pharmaceuticals (ALNY) P/E Ratio
P/E Ratio as of Jul 9, 2025: -153.31
Average-150.87
Median-151.70
Minimum-158.59
Maximum-142.66
-153.31
Past Month-9.57 (6.66%)
The P/E ratio for Alnylam Pharmaceuticals (ALNY) is -153.31 as of Jul 9, 2025. This represents a decrease of -22.35% compared to its 12-month average P/E ratio of -197.44. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Alnylam Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Alnylam Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Alnylam Pharmaceuticals to industry peers.
Alnylam Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Alnylam Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Alnylam Pharmaceuticals to industry peers.
Alnylam Pharmaceuticals (ALNY) P/E Ratio Insights
See Alnylam Pharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Alnylam Pharmaceuticals (ALNY)
Order type
Buy in
Order amount
Est. shares
0 shares
Alnylam Pharmaceuticals (ALNY) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $322.06 | -153.88 |
Jun 2, 2025 | $306.09 | -146.25 |
May 1, 2025 | $255.13 | -117.44 |
Apr 1, 2025 | $255.76 | -117.73 |
Mar 3, 2025 | $243.53 | -112.10 |
Feb 3, 2025 | $274.55 | -104.74 |
Jan 2, 2025 | $233.62 | -89.13 |
Alnylam Pharmaceuticals (ALNY) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -153.31 | +70.78% |
2024 | -89.77 | +94.56% |
2023 | -46.14 | +89.72% |
2022 | -24.32 | +3.18% |
2021 | -23.57 | +35.15% |
2020 | -17.44 | — |
FAQs About Alnylam Pharmaceuticals (ALNY) P/E ratio
The latest P/E ratio of Alnylam Pharmaceuticals (ALNY) is -153.31, as of Jul 9, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Alnylam Pharmaceuticals’s last 12-month average P/E ratio is -197.44, compared to its current P/E ratio of -153.31. This reflects a decrease of -22.35%.
Alnylam Pharmaceuticals’s current P/E ratio of -153.31 is lower than its last 12-month average P/E of -197.44. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Alnylam Pharmaceuticals’s average P/E ratio over the last 3 years is -97.91. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Alnylam Pharmaceuticals’s average P/E ratio over the last 5 years is -66.94. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.